Dose optimization of voriconazole/anidulafungin combination against Aspergillus fumigatus using an in vitro pharmacokinetic/pharmacodynamic model and response surface analysis: clinical implications for azole-resistant aspergillosis.

Siopi, Maria; Siafakas, Nikolaos; Vourli, Sophia; Mouton, Johan W; Zerva, Loukia; Meletiadis, Joseph.
J Antimicrob Chemother; 71(11): 3135-3147, 2016 11.
Artigo em Inglês | MEDLINE | ID: mdl-27494912